Cargando…
Mucopolysaccharidosis and Autophagy: Controversies on the Contribution of the Process to the Pathogenesis and Possible Therapeutic Applications
Mucopolysaccharidosis (MPS) consists of a group of 11 enzymatic defects which result in accumulation of undegraded glycosaminoglycans (GAG) in lysosomes. MPS is a severe metabolic disease for which only bone marrow/hematopoietic stem cell transplantation and enzyme replacement therapy are current th...
Autores principales: | Pierzynowska, Karolina, Gaffke, Lidia, Podlacha, Magdalena, Brokowska, Joanna, Węgrzyn, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021662/ https://www.ncbi.nlm.nih.gov/pubmed/31372809 http://dx.doi.org/10.1007/s12017-019-08559-1 |
Ejemplares similares
-
Underestimated Aspect of Mucopolysaccharidosis Pathogenesis: Global Changes in Cellular Processes Revealed by Transcriptomic Studies
por: Gaffke, Lidia, et al.
Publicado: (2020) -
Enhanced Efficiency of the Basal and Induced Apoptosis Process in Mucopolysaccharidosis IVA and IVB Human Fibroblasts
por: Brokowska, Joanna, et al.
Publicado: (2023) -
Impaired ion homeostasis as a possible associate factor in mucopolysaccharidosis pathogenesis: transcriptomic, cellular and animal studies
por: Gaffke, Lidia, et al.
Publicado: (2021) -
Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses
por: Rintz, Estera, et al.
Publicado: (2020) -
Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies
por: Pierzynowska, Karolina, et al.
Publicado: (2020)